Intelligent Bio Solutions

Intelligent Bio Solutions ROA

The Return on Assets (ROA) of Intelligent Bio Solutions (INBS) as of Oct 23, 2026 is -104.10 %. In the previous year, Return on Assets (ROA) was -128.11 % — a change of -18.74% (higher).

ROA

-104.10 %

YoY

-18.74%

Last updated:

In 2026, Intelligent Bio Solutions's return on assets (ROA) was -104.10 %, a -18.74% increase from the -128.11 % ROA in the previous year.

The Intelligent Bio Solutions ROA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROA
Date
ROA
Jan 1, 2019
-315.16 USD
Jan 1, 2020
-150.02 USD
Jan 1, 2021
-32.19 USD
Jan 1, 2022
-67.24 USD
Jan 1, 2023
-102.68 USD
Jan 1, 2024
-73.71 USD
Jan 1, 2025
-128.11 USD
Jan 1, 2026
-104.10 USD
The Intelligent Bio Solutions ROA history
YEARROAYoY
-104.10 %-18.74%
-128.11 %+73.80%
-73.71 %-28.21%
-102.68 %+52.69%
-67.24 %+108.87%
-32.19 %-78.54%
-150.02 %-52.40%
-315.16 %+56.69%
-201.13 %+294.70%
-50.96 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Intelligent Bio Solutions Stock analysis

What does Intelligent Bio Solutions do? Intelligent Bio Solutions, Inc. generates revenue through its Commercially available Intelligent Fingerprinting Products (IFPG) segment, which includes a portable drug screening system analyzing fingerprint sweat via a one-time cartridge and handheld reader. The company also develops diagnostic tests under the Development Stage Saliva Glucose Biosensor Platform (SGBP), targeting diabetic patients with a non-invasive saliva glucose biosensor (SGB) intended to replace finger-prick blood monitoring. Its biosensor platform supports multiple biological analyte detection for point-of-care diagnostic tests (POCT) in clinical chemistry, immunology, tumor markers, allergens, and endocrinology. The firm serves primary health practitioners and patients seeking non-invasive monitoring solutions. The company's product portfolio features the IFPG segment's portable drug screening system, which is sold to healthcare providers and law enforcement agencies for rapid drug testing. The SGBP segment focuses on developing the Saliva Glucose Biosensor (SGB), a point-of-care diagnostic test expected to address the needs of diabetic patients requiring frequent glucose monitoring without invasive procedures. The biosensor platform enables detection of multiple analytes, expanding the company's offerings in clinical chemistry and related diagnostic fields. Intelligent Bio Solutions, Inc. targets primary health practitioners and patients as key segments for its non-invasive diagnostic solutions. The IFPG segment's portable drug screening system is designed for use in clinical and law enforcement settings, while the SGBP segment's Saliva Glucose Biosensor aims to provide a convenient alternative to traditional blood glucose monitoring for diabetic patients. The company's development stage products focus on replacing invasive methods with real-time, non-invasive monitoring technologies. Intelligent Bio Solutions is one of the most popular companies on Eulerpool.

ROA Details

Understanding Intelligent Bio Solutions's Return on Assets (ROA)

Intelligent Bio Solutions's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Intelligent Bio Solutions's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Intelligent Bio Solutions's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Intelligent Bio Solutions’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Intelligent Bio Solutions stock

Return on Assets (ROA) of Intelligent Bio Solutions is -104.10 % in 2026.

Return on Assets (ROA) of Intelligent Bio Solutions changed from -128.11 % to -104.10 %, representing a -18.74% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Assets (ROA) Intelligent Bio Solutions since 2006 – with annual values, charts, and detailed analysis.

Return on Assets, also known as ROA, is a financial metric used to measure a company's profitability. It is used to determine how effectively a company uses its assets to generate profits. It is also referred to as the ratio of net income to total assets. ROA is an important indicator of a company's overall financial performance as it measures the company's ability to generate more profit from the assets it employs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Assets (ROA)'s Intelligent Bio Solutions with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Assets (ROA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Assets (ROA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Intelligent Bio Solutions

All Key Metrics — Intelligent Bio Solutions